ARK Genomic Revolution ETF
ARKG
508 hedge funds and large institutions have $2.24B invested in ARK Genomic Revolution ETF in 2021 Q1 according to their latest regulatory filings, with 161 funds opening new positions, 228 increasing their positions, 90 reducing their positions, and 62 closing their positions.
160% more first-time investments, than exits
New positions opened: 161 | Existing positions closed: 62
153% more repeat investments, than reductions
Existing positions increased: 228 | Existing positions reduced: 90
22% more funds holding
Funds holding: 415 → 508 (+93)
22% more capital invested
Capital invested by funds: $1.83B → $2.24B (+$403M)
0.89% less ownership
Funds ownership: 24.54% → 23.65% (-0.89%)
37% less funds holding in top 10
Funds holding in top 10: 27 → 17 (-10)
57% less call options, than puts
Call options by funds: $477M | Put options by funds: $1.11B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SDH
Sloy Dahl & Holst
Vancouver,
Washington
|
+$135M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$88.1M |
| 3 |
EP
Eversept Partners
New York
|
+$80M |
| 4 |
Morgan Stanley
New York
|
+$77.7M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$39.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$63.2M |
| 2 |
MCM
Mainstay Capital Management
Grand Blanc,
Michigan
|
-$39.4M |
| 3 |
SM
SG3 Management
Dorado,
Puerto Rico
|
-$22.5M |
| 4 |
UAM
UAS Asset Management
New York
|
-$19.2M |
| 5 |
LFA
Legend Financial Advisors
Pittsburgh,
Pennsylvania
|
-$18.5M |
ARKG Hedge Fund Activity: Q1 2021 in Review
508 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2021, worth a combined $2.24B — up 22% from $1.83B a quarter earlier.
Buyers outnumbered sellers: 161 funds opened new ARKG positions and 62 closed out — a net gain of 99 holders — while 228 added to existing stakes and 90 trimmed.
The largest buyer was Sloy Dahl & Holst, opening a new position worth an estimated $135M. The largest seller was Jane Street, cutting an estimated $63.2M.
- 508 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2021, up from 415 in Q4 2020.
- Funds reported $2.24B of ARK Genomic Revolution ETF stock for Q1 2021, up 22% quarter-over-quarter.
- 161 funds opened new ARK Genomic Revolution ETF positions in Q1 2021 and 62 closed out, a net change of +99 holders.
- The largest ARK Genomic Revolution ETF buyer in Q1 2021 was Sloy Dahl & Holst, an estimated $135M added.
- The largest ARK Genomic Revolution ETF seller in Q1 2021 was Jane Street, an estimated $63.2M sold.
Based on aggregated 13F filings for Q1 2021.